121 research outputs found

    Lego-Microfluidics Generated Magnetically Responsive Bifunctional Microcapsules with Encapsulated Phase Change Material

    Get PDF
    We report an innovative Lego-microfluidic technology for room temperature synthesis of highly monodispersed bifunctional microcapsules enclosing phase change material (PCM), exhibiting magnetic and thermal energy storage properties. Iron(II, III) oxide (Fe3_3O4_4) nanoparticle-embedded microcapsules encapsulating hexadecane (HD) are synthesized without external heating or cooling in just ∼80 s. The process involves forming oil-in-oil-in-water (O/O/W) double emulsion droplets with Norland Optical Adhesive (NOA) photopolymeric shell and consolidating them through on-the-fly shell polymerization using thiol–ene “click” chemistry. PCM content and magnetic properties were accurately manipulated by adjusting inner phase (PCM) flow rate and mass fraction of Fe3_3O4_4 nanoparticles in the middle (polymer) phase. Microcapsules with a shell thickness of 17.1 μm achieved a maximum PCM content of 63.3%. Thermogravimetric analysis (TGA) revealed significantly enhanced thermal stability of Fe3_3O4_4 nanoparticle-embedded microcapsules compared to pure PCM. Vibrating sample magnetometry (VSM) verified an increase in saturation magnetization and residual magnetization of microcapsules, having higher Fe3_3O4_4 nanoparticle content. Notably, the sample containing 1% Fe3_3O4_4 nanoparticles exhibited excellent magnetic properties, showcasing a saturation magnetization of 0.194 emu/g. Concurrently, the PCM microcapsules demonstrated high magnetic responsiveness and maneuverability

    Glycan shield of the ebolavirus envelope glycoprotein GP

    Get PDF
    The envelope glycoprotein GP of the ebolaviruses is essential for host cell entry and the primary target of the host antibody response. GP is heavily glycosylated with up to 17 N-linked sites, numerous O-linked glycans in its disordered mucin-like domain (MLD), and three predicted C-linked mannosylation sites. Glycosylation is important for host cell attachment, GP stability and fusion activity, and shielding from neutralization by serum antibodies. Here, we use glycoproteomics to profile the site-specific glycosylation patterns of ebolavirus GP. We detect up to 16 unique O-linked glycosylation sites in the MLD, and two O-linked sites in the receptor-binding GP1 subunit. Multiple O-linked glycans are observed within N-linked glycosylation sequons, suggesting crosstalk between the two types of modifications. We confirmed C-mannosylation of W288 in full-length trimeric GP. We find complex glycosylation at the majority of N-linked sites, while the conserved sites N257 and especially N563 are enriched in unprocessed glycans, suggesting a role in host-cell attachment via DC-SIGN/L-SIGN. Our findings illustrate how N-, O-, and C-linked glycans together build the heterogeneous glycan shield of GP, guiding future immunological studies and functional interpretation of ebolavirus GP-antibody interactions

    Glycan shield of the ebolavirus envelope glycoprotein GP

    Get PDF
    The envelope glycoprotein GP of the ebolaviruses is essential for host cell entry and the primary target of the host antibody response. GP is heavily glycosylated with up to 17 N-linked sites, numerous O-linked glycans in its disordered mucin-like domain (MLD), and three predicted C-linked mannosylation sites. Glycosylation is important for host cell attachment, GP stability and fusion activity, and shielding from neutralization by serum antibodies. Here, we use glycoproteomics to profile the site-specific glycosylation patterns of ebolavirus GP. We detect up to 16 unique O-linked glycosylation sites in the MLD, and two O-linked sites in the receptor-binding GP1 subunit. Multiple O-linked glycans are observed within N-linked glycosylation sequons, suggesting crosstalk between the two types of modifications. We confirmed C-mannosylation of W288 in full-length trimeric GP. We find complex glycosylation at the majority of N-linked sites, while the conserved sites N257 and especially N563 are enriched in unprocessed glycans, suggesting a role in host-cell attachment via DC-SIGN/L-SIGN. Our findings illustrate how N-, O-, and C-linked glycans together build the heterogeneous glycan shield of GP, guiding future immunological studies and functional interpretation of ebolavirus GP-antibody interactions
    corecore